Natera is the world leader in non-invasive prenatal testing, and is now expanding their focus to include non-invasive cancer diagnostics. This project leader will lead the clinical aspect of Natera’s rapidly growing new cancer initiative, and will be responsible for driving sample procurement, clinical trials and building key relationships in the field.
This individual will drive cancer focused research and clinical studies. This will involve helping to design clinical trials, including protocol and consent development, consenting patients for research, and training and coordinating with external research sites. They will create, submit, and maintain IRB approval and regulatory documentation for ongoing and new cancer research at Natera. They will also organize sample procurement and tracking, and will work with relevant collaborators as part of the research and clinical studies. Finally, this individual will initiate and maintain relationships with key opinion leaders in the cancer arena and develop an advisory board with a focus on cancer.
This individual should work independently, complete projects with autonomy and reliability.
- Minimum 5 years of experience in cancer research, genomics, or clinical care
- MD, PhD, or other similar degree level healthcare professional
- A demonstrated ability to work independently
- Outgoing and confident demeanor
- Independent thinker and persuasive communicator
- Detail oriented, with solid organization and time management skills
Natera develops genetic tests that help families have healthy children. The company has a CLIA-certified laboratory in California and unique technologies that combines expertise in molecular biology with advanced statistical techniques. These techniques enable Natera to analyze tiny quantities of DNA more accurately than anyone else in the world, primarily serving OBGYN physicians and their patients.
The team consists of over 300 statisticians, geneticists, doctors, laboratory technicians and software engineers from top-tier universities. Our technology has been funded by six grants from the National Institute of Health and a group of private investors led by Sequoia Capital and Orbimed investors. Natera is already providing genetic testing services to over 300 IVF centers, OBGYN practices, and partner laboratories in over 30 countries worldwide.
Natera affords equal employment opportunities to all qualified persons, regardless of race, color, religion, national origin, age, sex, disability, sexual orientation, gender expression, veteran or marital status.
Natera participates in E-Verify in the United States.
Natera is driven by a passion for elevating the science and utility of prenatal testing. The advent of the Information Age has created a...